Press Releases
September 7, 2021
Panbela to Present at Upcoming Investor Conferences
H.C. Wainwright 23rd Annual Global Investment Conference: September 13th to 15th, 2021
Oppenheimer Fall Healthcare Life Sciences & MedTech Summit: September 20-23
August 11, 2021
Panbela Provides Business Update and Reports Q2 2021 Financial Results
August 9, 2021
Panbela Announces Issuance of key U.S. Patent; Patent is for Claims of a Novel Process for the Production of SBP-101
Patent developed in collaboration with Syngene International Ltd
July 28, 2021
Panbela Schedules Conference Call on August 11 to Report 2021 Second Quarter Financial Results
July 7, 2021
Panbela to Present at Access to Giving Virtual Conference July 15 at 10:30 a.m. ET
July 2, 2021
Panbela Announces Closing of $10.0 Million Bought Deal Offering of Common Stock
June 30, 2021
Panbela Increases Previously Announced Bought Deal Offering of Common Stock to $10.0 Million
June 29, 2021
Panbela Announces $5.0 Million Bought Deal Offering of Common Stock
June 4, 2021
Panbela Presents Clinical Data on Phase 1b Clinical Trial of SBP-101 in Combination with Gemcitabine and Nab-Paclitaxel in Patients with Metastatic PDA at 2021 ASCO Annual Meeting
View/download poster presentation »
Events & Presentations